To initially explore the impact of NAMPT‐mediated NAD+ metabolism on the efficacy of anti‐PD‐L1 immunotherapy in cervical cancer, we established a subcutaneous tumor model in C57BL/6 mice using U14‐luc cells. The gene discussed is CD274; the disease is cervical carcinoma.